Direct-To-Consumer Genetic Testing Kits Vary in Predictions of Disease Risk
By Medical Xpress,
Medical Xpress
| 07. 17. 2013
An in-depth analysis and comparison study conducted by investigators at Emory's Rollins School of Public Health demonstrated variations in predicted disease risks by companies that offer direct-to-consumer personal genome testing.
Led by Cecile Janssens, PhD, research professor of Epidemiology, the team investigated DNA test results from three "direct- to-consumer" genome testing companies (23andMe, deCODEme, and Navigenics) to assess and compare their predictive abilities. Results show that predicted risks differed among the companies and were contradictory for certain traits in certain individuals.
The complete findings are available in the online edition of Genetics in Medicine.
"Although two of the companies that we studied are no longer operating, genotyping and sequencing is becoming less expensive and testing such as this is increasingly popular," explains Janssens. "The methods used for predicting these types of results are of important concern."
Test results provided by the three companies indicated an individual's risks for a large number of diseases. The study was conducted by creating DNA data for a hypothetical population of 100,000 individuals which is a less expensive and equally valid method for demonstrating the...
Related Articles
By Tania Fabo, Truthout | 02.28.2026
The reproductive tech company Orchid recently launched a genetic test that promises a whole genome sequencing report for embryos. It is the first such test commercially available to couples undergoing in vitro fertilization (IVF) and claims to detect things like...
By Pete Shanks
| 02.27.2026
Last month, we published “The Shameful Legacy of Tuskegee” which focused on a proposed experiment in Guinea-Bissau. The study’s plan echoed the notorious Tuskegee disaster, withholding safe, effective vaccines against hepatitis B from some newborns while inoculating others. It was to be financed by the U.S. but performed by a controversial Danish team. That project provoked a multi-national outcry, leading to a remarkable response from the World Health Organization:
WHO has significant concerns regarding the study’s scientific...
By Jenn White, NPR | 02.26.2026
By Vittoria Vardanega, SWI swissinfo.ch | 02.13.2026
In recent years, sperm donation has produced family trees of unprecedented size, stretching across countries and, in some cases, continents. Stories of “mass donors” have captured public attention, most recently through the Netflix documentary series, The Man with 1,000 Kids...
